Effect of orlistat during individualized comprehensive life-style intervention on visceral fat in overweight or obese PCOS patients
Sign Up to like & getrecommendations! Published in 2022 at "Gynecological Endocrinology"
DOI: 10.1080/09513590.2022.2089108
Abstract: Abstract Objective To investigate the effect of orlistat combined with drospirenone/ethinylestradiol tablets (DRSP/EE) on the visceral fat area (VFA) compared to DRSP/EE-alone in overweight or obese patients with polycystic ovary syndrome (PCOS). Methods 90 PCOS… read more here.
Keywords: effect orlistat; group; overweight obese; pcos patients ... See more keywords
The Effect of Orlistat on Sterol Metabolism in Obese Patients
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2022.824269
Abstract: Background Orlistat, a reversible inhibitor of pancreatic and gastric lipase, is known to have anti-obesity and antioxidant properties. Cholesterol intermediates and metabolites have diverse and important functions in cardiovascular disease. Therefore, we aimed to evaluate… read more here.
Keywords: group; effect orlistat; sterol metabolism; orlistat sterol ... See more keywords